Clinical Trial

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Name: P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety — clinical trial record (NCT06973577)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety

Protocol Amendment History 1 change

critical Trial completed 2026-05-07

Trial Details

NCT Number	NCT06973577
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Enrollment	315 participants
Start Date	2025-03-26
Primary Completion	2026-04-22 (estimated)
Study Completion	2026-04-29 (estimated)
Updated on ClinicalTrials.gov	2026-05-06